Effect of pregnancy, mode of administration and neonatal age on the pharmacokinetics of zalcitabine (2',3'-dideoxycytidine) in the pigtailed macaque (Macaca nemestrina)

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 5, 1997, Pages 687-693

  Tuntland, Tove ^a   Nosbisch, Connie ^a   Unadkat, Jashvant D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ZALCITABINE;

AMNION FLUID; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG INFUSION; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MACACA; MALE; NEWBORN; NONHUMAN; PLASMA CLEARANCE; PREGNANCY; SIMULATION; STEADY STATE;

EID: 0030734499     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/40.5.687     Document Type: Article

References (28)

1. Tovo, P. A., de Martino, M., Gabiano, C., Galli, L., Cappello, N., Ruga, E. et al. (1996). Mode of delivery and gestational age influence perinatal HIV-1 transmission. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 11, 88-94.
2. Connor, E. & McSherry, G. (1994). Treatment of HIV infection in infancy. Clinics in Perinatology 21, 163-77.
3. Boyer, P. J., Dillon, M., Navaie, M., Deveikis, A., Keller, M., O'Rourke, S. et al. (1994). Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery. Journal of the American Medical Association 271, 1925-30.
4. Lipsky, J. J. (1993). Zalcitabine and didanosine. Lancet 341, 30-2.
5. Toltzis, P., Mourton, T. & Magnuson, T. (1994). Comparative embryonic cytotoxicity of antiretroviral nucleosides. Journal of Infectious Diseases 169, 1100-2.
6. Tuntland, T., Nosbisch, C., Baughman, W. L., Massarella, J. W. & Unadkat, J. D. (1996). Mechanism and rate of the placental transfer of zalcitabine (2′,3′-dideoxycytidine) in Macaca nemestrina. American Journal of Obstetrics and Gynecology 174, 856-63.
7. Morton, W. R., Knitter, G. H., Smith, P. M., Susor, T. G. & Schmitt, K. (1987). Alternatives to chronic restraint of nonhuman primates. Journal of the American Veterinary Medical Association 191, 1282-6.
8. Roberts, W. L., Buckley, T. J., Rainey, P. M. and Jatlow, P. I. (1994). Solid-phase extraction combined with radioimmunoassay for measurement of zalcitabine (2′,3′-dideoxycytidine) in plasma and serum. Clinical Chemistry 40, 211-5.
9. Gibaldi, M. & Perrier, D. (1982). Pharmacokinetics, 2nd edn. Marcel Dekker Inc., New York.
10. Rocci, M. L. & Jusko, W. J. (1983). LAGRAN program for area and moments in pharmacokinetic analysis. Computer Programs in Biomedicine 16, 203-16.
11. Reynolds, F. & Knott, C. (1989). Pharmacokinetics in pregnancy and placental drug transfer. Oxford Reviews in Reproductive Biology 11, 389-449.
12. Nau, H. (1987). Clinical pharmacokinetics in pregnancy and perinatology. II. Penicillins. Developmental Pharmacology and Therapeutics 10, 174-98.
13. Jeffries, W. S. & Bochner, F. (1988). The effect of pregnancy on drug pharmacokinetics. Medical Journal of Australia 149, 675-7.
14. Leppik, I. E. & Rask, C. A. (1988). Pharmacokinetics of antiepileptic drugs during pregnancy. Seminars in Neurology 8, 240-6.
15. Pereira, C. M., Nosbisch, C., Winter, H. R., Baughman, W. L. & Unadkat, J. D. (1994). Transplacental pharmacokinetics of dideoxyinosine in pigtailed macaques. Antimicrobial Agents and Chemotherapy 38, 781-6.
16. Lopez-Anaya, A., Unadkat, J. D., Schumann, L. A. & Smith, A. L. (1990). Pharmacokinetics of zidovudine (azidothymidine). I. Transplacental transfer. Journal of Acquired Immune Deficiency Syndromes 3, 959-64.
17. Odinecs, A., Nosbisch, C., Keller, R. D., Baughman, W. L & Unadkat, J. D. (1996). In vivo maternal-fetal pharmacokinetics of stavudine (2′,3′-didehydro-3′-deoxythymidine) in pigtailed macaques (Macaca nemestrina). Antimicrobial Agents and Chemotherapy 40, 196-202.
18. Unadkat, J. D. & Pereira, C. M. (1994). Maternal-fetal transfer and fetal toxicity of anti-HIV drugs: a review. Trophoblast Research 8, 67-82.
19. Maish, W. A. (1993). Drug therapy for human immunodeficiency virus infection in children. Journal of Pediatric Health Care 7, 177-84.
20. Pizzo, P. A., Wilfert, C. M. & The Pediatric AIDS Siena Workshop II. (1995). Markers and determinants of disease progression in children with HIV infection. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 8, 30-44.
21. Assael, B. M. (1982). Pharmacokinetics and drug disposition during postnatal development. Pharmacology and Therapeutics 18, 159-97.
22. Connor, E. & McSherry, G. (1994). Treatment of HIV infection in infancy. Clinics in Perinatology 21, 163-77.
23. McLeod, H. L. & Evans, W. E. (1992). Pediatric pharmacokinetics and therapeutic drug monitoring. Pediatrics in Review 13, 413-21.
24. Warner, A. (1986). Drug use in the neonate: interrelationships of pharmacokinetics, toxicity and biochemical maturity. Clinical Chemistry 32, 721-7.
25. Klecker, R. W., Collins, J. M., Yarchoan, R. C., Thomas, R., McAtee, N., Broder, S. et al. (1988). Pharmacokinetics of 2′,3′-dideoxycytidine in patients with AIDS and related disorders. Journal of Clinical Pharmacology 28, 837-42.
26. Lopez-Anaya, A., Unadkat, J. D., Schumann, L. A. & Smith, A. L. (1990). Pharmacokinetics of zidovudine (azidothymidine). II. Development of metabolic and renal clearance pathways in the neonate. Journal of Acquired Immune Deficiency Syndromes 3, 1052-8.
27. Pereira, C., Nosbisch, C. & Unadkat, J. D. (1994). Pharmacokinetics of dideoxyinosine in neonatal pigtailed macaques. Antimicrobial Agents and Chemotherapy 38, 787-9.
28. Keller, R. D., Nosbisch, C. & Unadkat, J. D. (1995). Pharmacokinetics of stavudine (2′,3′-didehydro-3′-deoxythymidine) in the neonatal macaque (Macaca nemestrina). Antimicrobial Agents and Chemotherapy 39, 2829-31.